Protein Medicinal Chemistry with an Expanded Genetic Code
Ho Cho, Ambrx, Inc., La Jolla, CA

Novel gene co-expression and bioprocess strategies enabled by synthetic biology
Thomas Vogl¹, Thomas Kickenweiz¹, Lukas Sturmberger¹, Andrea Camattari¹ and Anton Glieder², (1)Institute for Molecular Biotechnology, Graz University of Technology, Graz, Austria, (2)Molecular Biotechnology/TU Graz, Austrian Centre of Industrial Biotechnology, Graz, Austria

Expression of antibodies in SHuffle
Mehmet Berkmen, New England Biolabs, Ipswich, MA

Break/Exhibits open

Bispecific Antibody Production in E. coli: Half the Story
James Giulianotti and Dorothea Reilly, Early Stage Cell Culture, Genentech Inc., South San Francisco, CA

Strain engineering to control a product quality attribute in Escherichia coli recombinant protein production processes
Karthik Veeravalli and Michael Laird, Late Stage Cell Culture Department, Genentech, Inc, South San Francisco, CA

Binary expression phenomena for high titer and scalable production of a fusion-free cysteine knot protein in E. coli
Varnika Roy¹, Mark Berge¹, Robert Roth², Rajesh Chitta¹, Sucheta Vajrala¹ and Ronald G. Schoner¹, (1)Process Cell Culture and Fermentation, MedImmune, Gaithersburg, MD, (2)Discovery Sciences, AstraZeneca, Molndal, Sweden